Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Inside the Data: Prof. Donal on the Tri.Fr Extended Follow-up Results
Author(s): Erwan Donal Added: 2 weeks ago
ACC 2026 - Two randomised trials position TriClip TEER as a transformative option in TR, delivering significant reductions in heart failure hospitalisations and supporting earlier intervention in clinical practice.Prof Erwan Donal (Hospital Pontchaillou of Rennes, Rennes, FR) joins us on-site at ACC 2026 to share the findings from two randomised trials (Tri.Fr and TRILUMINATE Pivotal)… View more

Intervention

Heart Failure
ACC 2025: The ALPACA Phase 2 Trial
Author(s): Steven E Nissen Added: 1 year ago
ACC 2025 - 540-day follow up of lepodisiran in patients with elevated lipoprotein(a) (Lp(A)) shows the extended duration of action of lepodisiran will allow infrequent dosing in the ongoing cardiovascular outcome trial.Dr Steven Nissen (Cleveland Clinic, Cleveland, US) joins us onsite at ACC to discuss the ALPACA phase 2 trial (NCT05565742), investigating the safety and efficacy of lepodisiran,… View more

Prevention & Chronic Conditions
Added: 1 year ago
Cardiac MRI (cMRI) 4-chamber cine view: Cardiac MRI cine sequence showing a mobile, markedly T2 hyperintense mass, attached to the mid interatrial septum, extending through the mitral valve. View more

Heart Failure
ESC 25: The HI-PRO Trial
Author(s): Gregory Piazza Added: 7 months ago
ESC Congress 2025 - HI-PRO shows apixaban 2.5mg twice daily reduced the risk of symptomatic recurrent venous thromboembolism when compared to placebo at 12 months.Dr Gregory Piazza (Brigham and Women's Hospital, US) joins us to discuss findings from the HI-PRO trial, evaluating extended-duration low-intensity apixaban versus placebo for secondary prevention in high-risk patients with provoked… View more

Anticoagulation

Vascular Disease and Surgery
Research Area(s) / Expertise:

Expertise

Intervention
Research Area(s) / Expertise:

Expertise

Intervention
ESC Preventive Cardiology 2025
Start date: Apr 03, 2025 End date: Apr 05, 2025
Dates: April 3-5, 2025Location: Milan, ItalyTheme: "Risk Factor Realities in 2025"ESC Preventive Cardiology 2025 is the premier annual congress of the European Association of Preventive Cardiology (EAPC), bringing together the leading community of healthcare professionals dedicated to cardiovascular disease prevention.The 2025 Milan congress offers an unparalleled opportunity to engage with the… View more
Research Area(s) / Expertise:

Expertise

Intervention
Job title: Research Fellow